HUGEL - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
79261502
Word Mark
HUGEL
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2020-03-02
Filing Date
2019-05-02
Mark Drawing
4000 - Standard character mark
Typeset
Law Office Assigned Location Code
M80
Employee Name
LAMONT, MIAH ROSENBERG
Statements
Goods and Services
Pharmaceutical and veterinary preparations for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases, and skin disorders; drugs for medical purposes; adjuvants for medical purposes; biological preparations for medical purposes, namely, pharmaceutical preparations comprising botulinum toxin, fragments of botulinum toxin; pharmaceutical preparations for treating neurological diseases and disorders; pharmaceutical preparations for treating dystonia; pharmaceutical preparations for the treatment of wrinkles; pharmaceutical preparations for the treatment of spasm; pharmaceutical preparations for the treatment of pain; pharmaceutical agents for treating physically caused lesions; pharmaceutical preparations for use in treating urogenital system diseases and conditions; ophthalmic preparations; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for dental purposes; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; microorganisms for medical purposes; cultures of microorganisms for medical or veterinary use; bacteriological preparations for medical and veterinary use; chemical preparations for pharmaceutical purposes, namely, for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases, and skin disorders; botulinum toxin for medical use for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases, and skin disorders; appetite suppressants for medical purposes; medicated lotions for treating dermatological conditions; ointments for pharmaceutical purposes; analgesics; pharmaceutical agents affecting peripheral nervous system; bacterial poisons; vaccines; hyaluronic acid mixed with its derivatives and other polysaccharides, including or not including lidocaine, in ampoule form for medical purposes; pharmaceutical preparations mainly based on hyaluronic acid; medical gels for activation of tissues, namely, medical gels for hypodermic syringes for improving wrinkles; hyaluronic acid preparations for medical purposes, namely, fillers for skin and soft tissue used for skin moisturizing and improving wrinkles; modified hyaluronic acid preparations for medical purposes, namely, fillers for skin and soft tissue used for skin moisturizing and improving wrinkles; injectable dermal fillers; pre-filled syringes for medical purposes, namely, prefilled with pharmaceutical preparations in the nature of hyaluronic acid, modified hyaluronic acid, its derivatives or substances that have a similar effect to hyaluronic acid, for the treatment and management of skin and soft tissue or artificial prostheses
Goods and Services
Medical apparatus and instruments; medical apparatus; surgical apparatus and instruments for medical, dental or veterinary use; medical apparatus and instruments for plastic surgery; medical apparatus and instruments for the treatment of skin; sutures; suture for medical purpose; syringes for medical purposes and for injections; medical filler apparatus; medical filler syringes; dermatoplastic instruments; surgical instruments for use in cosmetic surgery and plastic surgery for skin; skin esthetic massaging apparatus; orthopaedic articles; dental apparatus and instruments; gloves for use in hospitals; masks for medical purposes; dermic implants for medical use, intended for filling of wrinkles or increasing volume; syringes for injecting medical substances for the skin, namely, used for the injection of hyaluronic acid for contouring lips and faces, scar correction and wrinkle reduction for medical purposes
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-07-23
Primary Code
005
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2019-07-23
Primary Code
010
Correspondences
Name
Y.P. LEE, MOCK & PARTNERS
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1370923
International Registration Date
2017-04-19
International Publication Date
2019-06-20
International Renewal Date
2027-04-19
Auto Protection Date
2020-12-20
International Status
001 - Request for extension of protection established
International Status Date
2019-06-20
Priority Claimed In
False
First Refusal In
True
Trademark Events
Event Date | Event Description |
2019-06-20 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |
2019-06-29 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
2019-07-23 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-07-23 | ASSIGNED TO EXAMINER |
2019-07-24 | NON-FINAL ACTION WRITTEN |
2019-07-25 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2019-07-27 | APPLICATION FILING RECEIPT MAILED |
2019-08-20 | REFUSAL PROCESSED BY MPU |
2019-08-20 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2019-09-06 | REFUSAL PROCESSED BY IB |
2020-03-02 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
2020-03-02 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
2020-11-25 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
2020-11-25 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2020-12-12 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
2021-03-02 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2021-03-02 | FINAL DISPOSITION NOTICE SENT TO IB |
2021-03-21 | FINAL DECISION TRANSACTION PROCESSED BY IB |